Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- |
| Jul 31, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Sep 05, 2003 |
Other
|
Other | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 90,000 | -- |
| Sep 05, 2003 |
Director, Ch, Pres. and Chief Exec. Off.
|
Director, Ch, Pres. and Chief Exec. Off. | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 225,000 | -- |
| Sep 12, 2003 |
President, Oncology Division
|
President, Oncology Division | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | -- |
| Sep 12, 2003 |
VP,Finance, Strategic Planning
|
VP,Finance, Strategic Planning | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Sep 12, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Sep 12, 2003 |
Director, Ch, Pres. and Chief Exec. Off.
|
Director, Ch, Pres. and Chief Exec. Off. | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 215,000 | -- |
| Sep 12, 2003 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- |
| Jun 10, 2004 |
Director, Chairman, CEO & President
|
Director, Chairman, CEO & President | Open market or private purchase of non-derivative or derivative security | 2,000 | $6.75 |
| Jun 21, 2004 |
President Oncology Division
|
President Oncology Division | Open market or private purchase of non-derivative or derivative security | 200 | $5.39 |
| Jun 21, 2004 |
President Oncology Division
|
President Oncology Division | Open market or private purchase of non-derivative or derivative security | 400 | $5.40 |
| Jun 21, 2004 |
Director, Chairman, CEO & President
|
Director, Chairman, CEO & President | Open market or private purchase of non-derivative or derivative security | 1,000 | $5.40 |
| Jul 10, 2004 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jul 10, 2004 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jul 10, 2004 |
Vice President Finance
|
Vice President Finance | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
